Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
32 33 Next >
If You Invested $100 In This Stock 15 Years Ago, You Would Have $400 Today
Tickers GILD
Tags BZI/POD GILD News
From Benzinga
XBB.1.5, which makes up 28% of new COVID cases in the U.S., fuels worries about a winter wave
Tickers BNTX GILD MRK MRNA
Tags BNTX GILD MRK
From MarketWatch
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Tickers GILD RHHBY
Tags GILD RHHBY Recent Press Releases
From Motley Fool
FTX Exchange's Assets Worth $3.5B Held By Bahamian Regulators, Italy PM To Meet Intel Over Chip Investment, New Oral COVID Antiviral Might Be Better Than Pfizer's Paxlovid: Today's Top Stories
Tickers BIDU FTT GILD HSY
Tags BIDU Biotech HSY
From Benzinga
New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
Tickers GILD PFE
Tags GILD General News
From Benzinga
This New Drug Could Be Gilead Sciences' Growth Catalyst
Tickers GILD
Tags Recent Press Releases Market News GILD
From Motley Fool
3 High-Yielding Dividend Stocks That Could See Hikes in January
Tickers GILD KMB PFE VTRS
Tags GILD Market News KMB
From Motley Fool
Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program
Tickers GILD JNCE
Tags Penny Stocks Briefs Biotech
From Benzinga
Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today?
Tickers GILD JNCE MRK
Tags JNCE MRK GILD
From InvestorPlace
Tesla, Apple, Lightjump, Southwest, Gilead: Why These 5 Stocks Are Drawing Investors' Attention Today
Tickers AAPL GILD LJAQ LUV
Tags Benzinga LUV TSLA
From Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Tickers GILD
Tags Earnings GILD BZI/POD
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags Benzinga REGN ESALY
From Benzinga
3 Stocks That Could Soar in a Santa Claus Rally
Tickers GILD NVCR PFE
Tags NVCR Market News Recent Press Releases
From Motley Fool
3 Nasdaq Stocks That Are Up 25% in 3 Months
Tickers BIIB GILD NVDA
Tags Recent Press Releases Market News NVDA
From Motley Fool
FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
Tickers GILD
Tags FDA News Market News
From Benzinga
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
Tickers AAL AAPL AMC AMZN
Tags XBI VBINX ES00
From MarketWatch
Analyzing Gilead Sciences's Short Interest
Tickers GILD
Tags Short Ideas Trading Ideas Market News
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
Tickers GILD MRK RCUS RHHBY
Tags Today's Market RCUS Market News
From InvestorPlace
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
Tickers AZN GILD LLY MDGL
Tags Trading Ideas Movers Health Care
From Benzinga
Why Is Gilead Sciences Stock Sliding Tuesday?
Tickers GILD
Tags Trading Ideas Movers why it's moving
From Benzinga
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
Tickers GILD RCUS
Tags GILD General News
From Benzinga
Beat the Dow Jones With This Unstoppable Dividend Stock
Tickers DJI GILD
Tags Recent Press Releases ^DJI Market News
From Motley Fool
Why Is Arcellx (ACLX) Stock Up 25% Today?
Tickers ACLX GILD
Tags NASDAQ:ACLX,NASDAQ:GILD ACLX GILD
From InvestorPlace
Gilead's Kite, Arcellx Ink Over $300M Collaboration Pact For Late-Stage Multiple Myeloma Candidate
Tickers ACLX GILD
Tags Contracts News why it's moving
From Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 15 Years
Tickers GILD
Tags Dividends Benzinga Market News
From Benzinga
Is Gilead Sciences a Buy?
Tickers GILD
Tags Market News Recent Press Releases GILD
From Motley Fool
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
Tickers ALLO BMY CRBU CRSP
Tags Penny Stocks CRSP Biotech
From Benzinga
Is Gilead Sciences Stock Still a Buy After Soaring in 2022?
Tickers GILD
Tags Market News Recent Press Releases GILD
From Motley Fool
Gilead Sciences Unusual Options Activity
Tickers GILD
Tags BZI/UOA Market News GILD
From Benzinga
Here’s how one hedge fund is going aginst the grain and beating the markets
Tickers ADM ALL BIIB BMWYY
Tags MPC RE BRK/B
From MarketWatch
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.